文献速递主动脉疾病

胸腹主动脉瘤开窗/分支腔内修复术后1年瘤囊回缩与长期生存改善相关

Aneurysm Sac Regression after Fenestrated and Branched Endovascular Repair for Thoracoabdominal Aortic Aneurysms Is Associated with Improved Long-Term Survival.
PubMed 文献 · Ann Vasc Surg · 2026-08-06

本研究为单中心回顾性队列,纳入68例胸腹主动脉瘤行开窗/分支腔内修复且1年有CTA的患者,按瘤囊变化分为回缩(≥5mm缩小)、稳定(±5mm)和增长(≥5mm增大),稳定与增长合并为未回缩。中位随访56.5个月,未回缩与全因死亡率升高独立相关(多变量HR 2.55,95%CI 1.14-5.71;P=0.023),且晚期再干预率更高(HR 3.03,95%CI 1.09-8.37;P=0.033)。

要点

  • f/bEVAR术后1年瘤囊未回缩与长期全因死亡率升高独立相关。
  • 未回缩患者晚期再干预需求更高,但再干预未增加死亡风险。
  • 1年CTA瘤囊动态可用于风险分层,指导个体化随访。

核心结论

  • 胸腹主动脉瘤f/bEVAR术后1年瘤囊未回缩与更差长期生存和更高再干预率相关。
  • 1年CTA瘤囊动态对不良结局有预测价值,可用于风险分层。

研究设计与样本

  • 回顾性单中心队列研究,纳入2006年4月至2025年3月间行f/bEVAR的胸腹主动脉瘤患者。
  • 共68例符合纳入标准,均于术后1年行CTA评估瘤囊直径变化。

主要发现

  • 1年瘤囊回缩24例(35.3%),未回缩44例(64.7%),其中稳定35例(51.5%)、增长9例(13.2%)。
  • 中位随访56.5个月,总死亡率为55.9%(38例)。
  • 未回缩与全因死亡率升高相关:单变量HR 2.78(95%CI 1.33-5.81;P=0.007),多变量HR 2.55(95%CI 1.14-5.71;P=0.023)。
  • 未回缩与晚期I/III型内漏无显著关联(HR 1.50,95%CI 0.48-4.64;P=0.48)。
  • 未回缩患者晚期再干预需求更高(HR 3.03,95%CI 1.09-8.37;P=0.033),但再干预未增加死亡风险(HR 0.95,95%CI 0.48-1.90;P=0.89)。

关键数值与推荐

  • 瘤囊变化定义:回缩为直径缩小≥5mm,稳定为变化±5mm,增长为增大≥5mm。
  • 稳定与增长合并为未回缩(失败回缩)。
  • 所有晚期再干预均为经皮方式:主体再衬/延伸5例,桥接支架相关14例,弹簧圈栓塞2例。

临床怎么用

  • f/bEVAR术后1年CTA评估瘤囊回缩情况,未回缩者应加强随访和再干预评估。
  • 瘤囊未回缩可作为风险分层工具,指导个体化治疗和监测方案。

局限性

  • 回顾性单中心研究,样本量较小(68例)。
  • 仅纳入1年时行CTA的患者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study evaluated the association between sac regression at 1 year and long-term outcomes after fenestrated and branched endovascular aortic repair (f/bEVAR) for thoracoabdominal aortic aneurysm (TAAA). METHODS: A retrospective single-center cohort study was conducted of patients who underwent f/bEVAR for TAAA between April 2006 and March 2025 and had computed tomography angiography (CTA) at 1 year. Sac diameter change was categorized as regression (≥5 mm decrease), stable (±5 mm change), or growth (≥5 mm increase). Stable and growth were combined as failure to regress. The primary outcome was all-cause mortality. Secondary outcomes included late type I/III endoleaks and late reintervention. Kaplan-Meier analysis and Cox models were used. RESULTS: Sixty eight patients met inclusion criteria. Sac regression 1 year after f/bEVAR occurred in 24 patients (35.3%), whereas 44 (64.7%) demonstrated failure to regress (35 stable, 51.5%; nine growths, 13.2%). Median age was 67.5 years (interquartile range [IQR] 65.0-74.8) and 74.0 years (IQR 68.0-76.8), and 12 (50.0%) and 32 (72.7%) patients were male for the aneurysm regression and failure to regress groups, respectively. During a median follow-up of 56.5 months, overall mortality was 55.9% (38 patients). In a univariable model, failure to regress was significantly associated with higher all-cause mortality (hazard ratio [HR] 2.78, 95% confidence interval [CI] 1.33-5.81; P = 0.007). This association was confirmed in multivariable analysis (HR 2.55, 95% CI 1.14-5.71; P = 0.023). Although there was no association between failure to regress and late type I or III endoleak (HR 1.50, 95% CI 0.48-4.64: P = 0.48), the need for late reintervention was higher for patients with failure to regress (HR 3.03, 95% CI 1.09-8.37; P = 0.033). Notably, all late reinterventions were percutaneous (five main body relinings/extensions; 14 bridging stent-related; two coiling procedures) and did not increase mortality risk (HR 0.95, 95% CI 0.48-1.90; P = 0.89). CONCLUSION: Aneurysm sac failure to regress at 1 year after f/bEVAR for TAAA is associated with worse long-term survival and increased reintervention rate. The predictive value of aneurysm sac dynamics at 1 year CTA, for adverse outcomes highlights its potential for risk stratification, guiding patient specific treatment regimen.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Huistra EWM, Tielliu IFJ, Gareb B, et al. Aneurysm Sac Regression after Fenestrated and Branched Endovascular Repair for Thoracoabdominal Aortic Aneurysms Is Associated with Improved Long-Term Survival. Ann Vasc Surg. 2026. PMID: 42562223. doi:10.1016/j.avsg.2026.07.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。